Patent No. EP4476216 (titled "Heterocyclic Glp-1 Agonists") was filed by Gasherbrum BIO on Feb 8, 2023. The application was issued on Dec 18, 2024.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents